Allegan-based Perrrigo Co. (Nasdaq: PRGO) said Monday that it has received final approval from the United States Food and Drug Administration to manufacture and market over-the-counter Cetirizine Cherry Syrup, 1mg/ml.
Shipments will begin in the company’s fiscal first quarter 2011.
Cherry joins the currently available grape flavor cetirizine syrup in Perrigo’s product portfolio, giving patients a choice of store brand flavors.
The product will be marketed under store brand labels and is comparable to McNeil Consumer Healthcare’s Zyrtec Children’s Allergy Syrup, indicated for indoor and outdoor allergy relief. Brand sales for the Zyrtec brand of products, which includes cherry syrup, were $580 million for the last 52 weeks ending July 4.
Perrigo develops, manufactures and distributes OTC and generic prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients and consumer products. The company is the world’s largest manufacturer of OTC pharmaceutical products for the store brand market. The company’s primary markets and locations of manufacturing and logistics operations are the U.S., Australia, Israel, Mexico and the United Kingdom.
More at www.perrigo.com.